Skip to content

Efficacy and mechanism exploration of repetitive magnetic stimulation in patients with neurogenic lower urinary tract dysfunction of spinal cord injury

Efficacy and mechanism exploration of repetitive magnetic stimulation in patients with neurogenic lower urinary tract dysfunction of spinal cord injury

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088048
Enrollment
Unknown
Registered
2024-08-09
Start date
2024-03-10
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spinal cord injury

Interventions

Group A :TMS in M1
group B:magnetic stimulation in T12-L2
group C:magnetic stimulation in S2-4

Sponsors

West China hospital of Sichuan university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) According to SCI's International Standards for Neurological Classification of SCI (ISNCSCI) with incomplete SCI and the spinal shock phase has passed; (2) Completed UDS prompt NDO; (3) Stable vital signs; (4) Age 18-80 years; (5) The course of the disease is less than 2 years; (6) The subject is willing to participate in this study and sign the informed consent form, and can cooperate with the experimental intervention and follow-up.

Exclusion criteria

Exclusion criteria: (1) Inability to receive magnetic stimulation or examination (intracranial hypertension, metallic foreign body, hemorrhage, epilepsy, after electronic implantation, pregnancy women, etc.); (2) Subject has cognitive dysfunction or other diseases that are unable to complete examinations, evaluations, and treatments; (3) The subject is in critical condition, organ failure, tumor, etc.; (4) The subject is unable to cooperate with the completion of the examination, evaluation and follow-up required by the trial; (5) Subjects were unwilling/unable to follow the study design plan for treatment and follow-up due to subjective and objective factors.

Design outcomes

Primary

MeasureTime frame
urodynamic study;

Secondary

MeasureTime frame
Diffusion Tensor Imaging of Spinal cord;Motor Evoke Potential;American Spinal Injury Association impairment score;bladder diary;Neurogenic Bladder Symptom Score;

Countries

China

Contacts

Public ContactPan Hongxia

West China hospital of Sichuan university

510719218@qq.com+86 138 8179 2207

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026